Xencor's stock drops 65%, hitting all-time lows. Focus shifts to autoimmune research, but no near-term catalysts. Read why ...

“Our vision at Quantumzyme is to help reshape the future of industrial chemistry through the power of enzymatic catalysis,” stated Naveen Kulkarni, CEO of Quantumzyme. “By combining AI and ...

In a groundbreaking study, a series of zirconium-based metal-organic frameworks (Zr-MOFs) were successfully synthesized in ...

The Global Biocatalyst Market is valued at approximately USD 1.17 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.67% over the forecast period 2024-2032. Read the ...

One of the most significant challenges facing current nanozyme technologies is the lack of well-defined active sites, which ...

“Our results show that enzymes are not just chemical catalysts, but also mechanical objects finely tuned by evolution. It’s a new way of thinking about life—as a programmable physical system,” ...

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

The scientific community is abuzz with a groundbreaking discovery that could redefine the future of clean energy.

Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to reflect on its successful participation in the 9th International ...

A new approach to enzyme engineering has overcome many of the operating challenges associated with large-scale bio-based ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.